SCHEMBL29628344

SCHEMBL29628344

[2H]C(Br)C(=O)c1ccc(F)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 2/20 0.44
TAS1R1 Q7RTX1 2/20 0.44
TAS1R2 Q8TE23 2/20 0.44
GSK3B P49841 1/20 0.43
KCNQ3 O43525 1/20 0.41
KCNQ2 O43526 1/20 0.41
KCNE1 P15382 1/20 0.41
KCNQ1 P51787 1/20 0.41
TSHR P16473 1/20 0.41
PIK3CA P42336 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
CASP3 P42574 1/20 0.39
KMT2A Q03164 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SLC2A1 P11166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311275 0.86 GSK3B (0.60) TAS1R3TAS1R1TAS1R2GSK3BKCNQ3
SCHEMBL29391582 0.86 GSK3B (0.60) TAS1R3TAS1R1TAS1R2GSK3BKCNQ3
SCHEMBL27503767 0.80 KCNQ3 (0.44) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
SCHEMBL7144096 0.80 GSK3B (0.59) TAS1R3TAS1R1TAS1R2GSK3BKCNQ3
SCHEMBL22570695 0.79 KCNQ3 (0.43) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
SCHEMBL2538090 0.79 TSHR (0.58) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
SCHEMBL20084007 0.77 KCNQ3 (0.47) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
SCHEMBL4712029 0.77 NPC1 (0.47) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
Hydrochloric Acid SCHEMBL29391461 0.77 KMO (0.44) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
SCHEMBL11743831 0.76 USP5 (0.49) TSHRNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3997096-A1 NEW HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2022-05-18 EP disclosed